M. Volz

526 total citations
24 papers, 422 citations indexed

About

M. Volz is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Volz has authored 24 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Volz's work include Enzyme function and inhibition (3 papers), Biochemical and Molecular Research (3 papers) and Pharmacological Effects and Assays (3 papers). M. Volz is often cited by papers focused on Enzyme function and inhibition (3 papers), Biochemical and Molecular Research (3 papers) and Pharmacological Effects and Assays (3 papers). M. Volz collaborates with scholars based in Germany, Ireland and France. M. Volz's co-authors include Gerhard Pfleiderer, J. John Holbrook, H. G. Eckert, Friedrich Cavagna, O Christ, Péter Hajdú, M. Schlepper, Christoph Woenckhaus, M. Carmody and Veselin Mitrović and has published in prestigious journals such as Analytical Biochemistry, Journal of Hepatology and European Journal of Biochemistry.

In The Last Decade

M. Volz

24 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Volz Germany	10	150	69	64	57	49	24	422
Hideyo Noguchi Japan	17	190 1.3×	39 0.6×	58 0.9×	52 0.9×	128 2.6×	55	774
G. S. Rao Germany	11	122 0.8×	25 0.4×	39 0.6×	14 0.2×	47 1.0×	16	438
Masafumi Hisaoka Japan	13	121 0.8×	33 0.5×	31 0.5×	24 0.4×	48 1.0×	28	404
Conny Bogentoft Sweden	14	165 1.1×	24 0.3×	65 1.0×	14 0.2×	40 0.8×	61	617
James A. Oppermann United States	11	100 0.7×	54 0.8×	46 0.7×	12 0.2×	49 1.0×	17	495
Tillement Jp France	11	118 0.8×	19 0.3×	41 0.6×	26 0.5×	76 1.6×	72	381
Johan Wemer Netherlands	15	103 0.7×	53 0.8×	44 0.7×	49 0.9×	102 2.1×	34	460
Dennis K.J. Gorecki Canada	17	156 1.0×	15 0.2×	77 1.2×	20 0.4×	28 0.6×	38	578
A Nomura Japan	13	122 0.8×	96 1.4×	29 0.5×	11 0.2×	54 1.1×	53	542
Goro Kominami Japan	7	85 0.6×	36 0.5×	43 0.7×	38 0.7×	22 0.4×	33	452

Countries citing papers authored by M. Volz

Since Specialization

Citations

This map shows the geographic impact of M. Volz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Volz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Volz more than expected).

Fields of papers citing papers by M. Volz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Volz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Volz. The network helps show where M. Volz may publish in the future.

Co-authorship network of co-authors of M. Volz

This figure shows the co-authorship network connecting the top 25 collaborators of M. Volz. A scholar is included among the top collaborators of M. Volz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Volz. M. Volz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Volz, M., et al.. (2001). Sproedbruchsicherheit im Stahlbau. Stahlbau. 70(9). 1 indexed citations

Volz, M., et al.. (1995). Steady-state plasma kinetics of slow-release propafenone, its two isomers and its main metabolites.. PubMed. 45(3). 246–9. 8 indexed citations

Baader, E., M. Bickel, Douglas D Damm, et al.. (1994). Interference in Clinical Laboratory Tests, with Special Regard to the Bilirubin Assay: Effects of a Metabolite of the New Prolyl 4-Hydroxylase Inhibitor, Lufironil. Clinical Chemistry and Laboratory Medicine (CCLM). 32(7). 515–520. 4 indexed citations

Volz, M., et al.. (1994). Influence of temperature and short-term storage on the stability of norepinephrine in plasma samples. Analytical and Bioanalytical Chemistry. 348(10). 696–698. 1 indexed citations

Volz, M., et al.. (1994). Steady-state plasma concentrations of propafenone--chirality and metabolism.. PubMed. 32(7). 370–5. 8 indexed citations

Volz, M., et al.. (1991). Pharmacokinetics and metabolism of HOE 077. Journal of Hepatology. 13. S48–S62. 7 indexed citations

Donohue, John A., et al.. (1989). Pharmacokinetics of amlodipine in renal impairment. European Journal of Clinical Pharmacology. 36(2). 205–208. 5 indexed citations

Mitrović, Veselin, et al.. (1989). Hemodynamic, antiischemic, and neurohumoral effects of enoximone in patients with coronary artery disease. American Heart Journal. 117(1). 106–111. 12 indexed citations

Mitrović, Veselin, Jörg Neuzner, Abdullatif Husseini, M. Volz, & M. Schlepper. (1989). The Influence of Various Degrees of Cardiac Failure, Chronic Medical Treatment, and Acute Additional Enoximone Application on the Parameters of the Vasopressor System. Journal of Cardiovascular Pharmacology. 14(Supplement). S50–S50. 3 indexed citations

10.

Laher, M. S., et al.. (1988). Pharmacokinetics of Amlodipine in Renal Impairment. Journal of Cardiovascular Pharmacology. 12(Supplement 7). S60–S63. 28 indexed citations

11.

Schlepper, M., et al.. (1988). [Hemodynamic, anti-ischemic, metabolic and neurohumoral effects of enoximone (MDL 17,043) in patients with coronary disease].. PubMed. 77(10). 660–7. 1 indexed citations

12.

Eckert, H. G., et al.. (1985). Studies in cattle on the disposition of the anti-trypanosomal drug diminazene diaceturate (Berenil).. PubMed. 36(4). 199–204. 31 indexed citations

13.

Volz, M., et al.. (1984). Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man.. PubMed. 34(10B). 1435–47. 36 indexed citations

14.

Volz, M., et al.. (1980). Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone).. British Journal of Clinical Pharmacology. 10(S2). 299S–308S. 87 indexed citations

15.

Volz, M., et al.. (1979). Kinetics and metabolism of clobazam in animals and man.. British Journal of Clinical Pharmacology. 7(S1). 41S–50S. 74 indexed citations

16.

Holbrook, J. John, et al.. (1967). The Importance of SH-Groups for Enzymic Activity. 7. The Amino Acid Sequence around the Essential SH-Group of Pig Heart Lactate Dehydrogenase, Isoenzyme I.. European Journal of Biochemistry. 1(4). 476–481. 41 indexed citations

17.

Volz, M., et al.. (1967). Application of Crotalus atrox venom α-protease for amino acid sequence determination. Analytical Biochemistry. 21(2). 219–226. 15 indexed citations

18.

Holbrook, J. John, et al.. (1967). The Importance of SH-Groups for Enzymic Activity. European Journal of Biochemistry. 1(4). 476–481. 36 indexed citations

19.

Woenckhaus, Christoph & M. Volz. (1966). Synthese und biochemische Eigenschaften des Nicotinamid‐phenyl‐dinucleotids. Chemische Berichte. 99(5). 1712–1717. 6 indexed citations

20.

Woenckhaus, Christoph, M. Volz, & G. Pfleiderer. (1964). Darstellung und Eigenschaften von Nikotinamid-N¹-β-ᴅ-gluco-pyranosylphosphat und Nikotinamidglucosid-Adenin-Dinucleotid. Zeitschrift für Naturforschung B. 19(6). 467–470. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact